MCP-1 mRNA Expression in Basal Keratinocytes of Psoriatic Lesions  by Gillitzer, Reinhard et al.
MCP-l D1RNA Expression in Basal Keratinocytes 
of Psoriatic Lesions 
Reinh ard Gillitzer, * Klaus Wolff,-, Dan Tong, t Christoph Mi.iller,:~ Teizo Yoshimura,§ Albert A. Hartmann, * 
Georg Stingl, t and Rudolf Berged 
• Department of Dermatology, University of Wiirzburg Medical School, Wiirzburg, Germany; tDepartment of Dernlatology I, 
University of Vienna Medical School, Vienna, Austria; j:Department of Pathology, University of Bern Medical School, Bern, 
Switzerland; and §National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland, U.S.A. 
In addition to hyperpro liferation ofkeratinocytes, psoriasis is 
characterized by pronounced leukocytic infiltration. In con-
trast to the epidermal localization of neutrophils and T lym-
phocytes, macrophages are almost exclusively restricted to 
the dermal compartment. By immunohistologic analysis, 
these dermal macrophages were mainly encountered in the 
papillary dermis and arranged along the rete ridges in close 
proximity to proliferating keratinocytes. Monocyte che-
moattractant protein (M CP-i ) anti-sense RNA probes 
yielded abundant signa ls over the proliferating basal keratino-
H istopathologically, psoriasis is characterized by an excessive proliferation ofkeratinocytes as well as by a pronounced inflammatory infiltrate. The juxta-position of proliferating keratinocytes and immu-nocompetent cells has been taken to suggest that 
immunologic processes are involved in the pathogenesis of psoriasis 
[1]. To better understand the underlying mechanisms, we have in-
vestigated the potential factors responsible for the abnormal cutane-
ous topobiology of the infiltrating leukocytes . 
In psoriasis, the altered spatial distribution of infiltratillg leuko-
cytes includes neutrophils that mainly accumulate in the uppermost 
rete malpighii as singly scattered ce ll s or in Kogoj's pustules and 
Munroe's microabscesses. We have recently shown by RNA-RNA 
in situ hybridization (2) that, in psoriatic lesions, transcripts for the 
chemotactic cytokine N AP-l / IL-8 (neutrophil-activating peptide 
(synonymous with neutrophil attractant protein-l)/interleukin 8, 
reviewed in (3)) are mainly, if not exclusively, expressed in the 
upper layers of the epidermis. This phenomenon may contribute to 
a) the influx of neutrophils into the epidermis and their further 
migration to the upper layers, eventually resulting in the formation 
of subcorneal abscesses, and b) a hyperproliferation ofkeratinocytes 
Manuscript received July 22, 1992; accepted for publication April 12, 
1993. 
This work was presented in part at the 19th annual meeting of the Ar-
beitsgemeinschaft Dermatologische Forschung (ADF), Graz, Austria, No-
vember 9 - I I, 1991 and at the Twenty-Second Annual Meeting of the 
European Society for Dermatological Research (ESDR), London, U.K., 
April 4 - 7, 1992. 
Reprint requests to: Dr. Reinhard Gi llitzer, Department of Dermatology, 
University ofW iirzburg Medical School,J osef-Schneider-Strasse 2, 0-8700 
W iirzburg, Germany. 
Abbreviations: MCP-I, monocyte chemoattractant protein-I; NAP-I/ 
IL-8, neutrophil-activating peptide I (synonymous with neutrophil attrac-
tant protein - I )/interlcukin 8. 
cytes of the tips of the rete ridges, and, to a lesser extent, in 
cells in the papillae. Thus, the strongest MCP-l message in 
psoriatic lesions is found above the dermal-epidermal junc-
tion and this may explain the characteristic sub-basal distri-
bution of dermal macrophages. These results suggest that 
MCP-l is important in regulating the interaction between 
proliferating keratinocytes and dermal macrophages in pso-
riasis pathogenesis. Key words: in situ hybridization, mono-
cyte-macrophage chemotaxis. ] Il1vest Dermato! 101:127-
131,1993 
(3). Likewise, T lymphocytes are not restricted to the dermal com-
partment in psoriatic lesions, and various cytokines and adhesion 
molecules have been implicated in regulating T-cell migration into 
the epidermis [1,4) . 
Surprisingly, potentially mobile CD 45 +, CD 68 + macrophages 
are almost exclusively restricted to the dermal compartment (there-
fore termed dermal macrophages) of psoriatic lesions, with only a 
few cells penetrating the basement membrane (unpublished obser-
vation). High densities of dermal macrophages are encountered in 
the papillary dermis, frequently arranged along the basement mem-
brane of the rete ridges and in close proximity to the extensively 
proliferating basal keratinocytes ([5) and unpublished observations). 
At present, neither the specific cytokines/chemotactic proteins nor 
the identity and location of the corresponding producer cells that 
contribute to this peculiar distribution of dermal macrophages in 
psoriatic lesions are known. 
Recently, a potent monocyte chemoattractant, the monocyte 
chemotactic protein-1 (MCP-1), also known as monocyte che-
moattractant and activating factor (MCAF) (8) or human JE r.rotein 
(9) has been isolated and sequenced [6,7) . T lymphocytes [10 , fibro-
blasts [11 ,12), endothelial cells [12,13), smooth muscle cells [13], 
and keratinocytes [14) have the potential to secrete MCP-1 in vitro. 
As all these cell types are integral components of psoriatic lesions, 
MCP-1 could be one of the factors responsible for monocyte/ma-
crophage chemotaxis in psoriasis. Among the multiple cytokines 
studied in psoriatic lesions ([16), reviewed in (17)), IL-l and TNF-a 
and TNF-P are known to induce MCP-l production [7,10,11, 
16,17). Moreover, early studies on MCP-1 have shown that plate-
let-derived growth factor-BB (PDGF-BB) stimulates fibroblasts to 
produce MCP-l (JE) (15)' So far, the role of MCP-1 in psoriatic 
lesions has not been adequately addressed. 
In the present study, we determined the magnitude and location 
of MCP-1 mRNA expression in psoriatic lesions. In addition, we 
investigated the spatial relationship of MCP-1 mRNA expression 
and macrophage localization. To address this issue we used immu-
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nohistology to type the inflammatory infiltrate, and ill situ hybrid-
ization to microanatomically localize these cytokines. 
MATERIALS AND METHODS 
Selection and Preparation of Skin Sections Fresh incisional biopsy 
specimens of Ie siona 1 and non-lesional skin of patients with untreated,long-
standing psoriasis were taken under local anesthesia (n = 9). For control 
purposes, biopsies were taken from five healthy volunteers. The material 
was snap-frozen and 4-llm cryostat sections were used for immunohistology 
and ill sitll hybridization. 
Immunohistology For immunohistology the following monoclonal an-
tibodies (MoAbs) were employed: MoAb anti-CD3 (Leu-4, at 1 : 400, Bec-
ton-Dickinson, Sunnyvale, CAl reacting with the T-cell receptor-associated 
CD3 antigen; MoAb anti-CD45 (HLe, at 1: 100, Becton-Dickinson) the 
lymphocyte common antigen, specific for a surface protein on all human 
leukocytes; MoAb anti-human neutrophil elastase (Dako-Elastase, at 1: 100, 
Dakopatts, Copenhagen, Denmark); MoAb S3 (a generous gift from Dr. 
Pawaresch, Department of Pathology, University of Kiel, Germany) react-
ing with proliferating cells; MoAb KiM7 (at 1: 2000, Behring Werke, Mar-
burg, Germany); KiMB (at 1 : 1000, Behring Werke) and anti-CD6B (PGM-
I, at 1 : 1000, Dakopatts) reacting with monocytes/macrophages, applied to 
detect macrophages of the skin. 
For single-color labeling a three-step streptavidin-biotin-peroxidase pro-
cedure was used, as described elsewhere [21]. After blocking Fc-receptors 
with 20% heat-inactivated sheep serum in phosphate-buffered saline (PBS), 
sections were incubated with specific MoAb overnight at 4 ° C, followed by 
biotin-conjugated sheep anti-mouse Ig (Amersham, Amersham, U.K.) and 
preformed streptavidin-biotin peroxidase complex (strept ABComplex-Per-
oxidase, Dakopatts) for 1 h at room temperature. Sections were thoroughly 
rinsed between each incubation step; 3 amino-9-ethylcarbazole (Sigma Co., 
St. Louis, MO) was used as peroxidase substrate. For control purposes spe-
cific MoAbs were replaced by isotype-matched IgG, which consistently 
yielded negative results. 
In Situ Hybridization 
Preparatioll of JSS-Labefed RNA Probes: MCP-1 cDNA was originally 
cloned by using the lambdaZap system [7] (Stratagene, La Jolla, CAl. For 
sense and anti-sense reaction products, T3 or T7 polymerase reactions were 
performed, respectively. Briefly, after linearization of plasmid DNA with 
appropriate restriction enzymes, 35S-labeled sense and anti-sense probes were 
obtained by ill vitro transcription with T3, T7, or SP6 RNA-polymerase 
synthesis reaction, respectively. The original linearized template cDNA was 
eliminated by DNase treatment (Pharmacia LKB Biotechnology). To facili-
tate penetration of probes into the cells/tissue, alkaline hydrolysis of the 
RNA probe at 60°C in a carbonate buffer (pH 10.2) was performed accord-
ing to the formula t (min) = (Lo - Lf)/0.11 X Lo X Lf(Lo = initial length 
in kb, Lf = final size in kb) [22], whereby an average length of 50-150 base 
pairs was generated. The size of35S-labeled RNA probes was checked after 
size reduction on a denaturating 6% polyacrylamide gel. Finally, after mul-
tiple ethanol precipitation steps, the radioactive riboprobe was adjusted to a 
specific activity of2 X 106 cpm/1l1 in 0.01 M Tris-HC1, pH 7.5, containing 
1 mM ethylenediaminetetraacetic acid (EDTA). Generally, 70-95% of 
UTP-radionucleotides were incorporated into the RNA probe. 
Hybridizatiol1 Procedure: The hybridization protocol described by Mueller et 
of [23] was used without any modificatiollS. Paraformaldehyde-fixed cryo-
stat sections were treated with proteinase K (Boehringer, Mannheim, Ger-
many) (1 Ilg/ml) for 30 min at 37 °C to facilitate the accessibility of the 
radioactive probes to cellular target mRN A. Afterwards, sections were re-
fixed in 4% paraformaldehyde, acetylated with acetic anhydride in 0.1 M 
triethanolamine (pH B.O, 10 min), dehydrated in graded alcohol, and air 
dried. Thereafter, sections were overlaid with 20 III of hybridization solu-
tion (50% formamide, 300 mM NaCl, 20 mM Tris-HC1, pH B.O, 5 mM 
EDTA, 1 X Denhardt's solution, 10% dextran sulfate, 100 mM dithiothrei-
tol, and 2 X 105 cpm/1l1 heat-denatured radioactive probe). The slides were 
mounted with coverslips, sealed, and hybridized at 46 - 47"C for 12-16 h. 
Every anti-sense and, for control purposes, every sense probe was hybridized 
with at least three sections of the same biopsy. RNase treatment was included 
as a control and consistently abrogated specific hybridization. After the 
hybridization, non-hybridized probes were removed by several high-strin-
gency washing procedures with 50% formarnide solution containing 2 X 
SSC and 5 mM EDTA at 54 - 57°C. To further minimize non-specific 
background, non-complementary unhybridized single-stranded probe RNA 
was digested with RNase A (20 Ill/ml) and RNase Tl (1 U/ml) 
(Boehringer) for 30 min at 37 °C. For autoradiography, slides were dipped in 
a NTB-2 Kodak solution (1 : 2 in BOO mM ammonium acetate) and were 
exposed for 1- 5 weeks at 4°C. For evaluation of the developed slides a Zeiss 
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Axiophot microscope equipped for polarized incident light (epipolarization) 
microscopy (Zeiss, Oberkochen, Germany) was used. 
RESULTS 
Immunohistology All sections investigated (n = 9) exhibited 
the typical histopathologic features of psoriasis (e.g., acanthosis , 
parakeratosis, Munroe's neutrophil-abscesses, pustules of Kogoj, 
elongated and distorted papillary vessels). All lesions showed a pro-
nounced leukocytic infiltrate that was mainly localized in the papil-
lary and upper reticular dermis, as shown by staining with MoAb 
anti-CD45. MoAb KiM7-, MoAb KiMS-, and MoAb anti-CD6S-
reactive cells (as revealed by sequential sectioning) were found to 
comprise a major portion of infiltrating cells in the dermal compart-
ment. These cells were clustered in particular high densities in the 
elongated papillae and were seldomly encountered in the lower 
epidermal compa.rtment (Fig 1). Frequently, they were aligned 
along the dermal side of the basement membrane of the elongated 
and often club-shaped rete ridges like a string of pearls (Fig 1). As 
opposed to CD6S+ dermal macrophages, which were infrequently 
detected in the epidermis, CD3+ lymphocytes were encountered as 
singly scattered cells in all epidermal layers of the lesion as previ-
ously shown [40]. However, the majority of CD3+ cells resided in 
the upper dermal compartment, mainly within clusters of infiltrat-
ing leukocytes (CD45+ cells> CD3+ cells). 
Clusters of neutrophils within the upper stratum malphighii and 
the parakeratotic layers of long-standing lesions of chronic plaque 
psoriasis were detected with a MoAb specific for human neutrophil 
elastase. 
The MoAb S3 was used to identify the proliferating keratinocytes 
in psoriatic lesions. Cross reactivity with cytokeratin as opposed to 
analysis with MoAb Ki 67 [24] (J. Gerdes, personal communica-
tion) was not observed. In contrast to normal human skin from 
healthy volunteers, proliferating keratinocytes in psoriatic lesions 
were not only detected in the basal layer of the rete ridges but were 
also encountered in the second and third suprabasal layer of the 
epidermis (Fig 2) . The increased proliferation of keratinocytes in 
these layers as compared to normal skin is in agreement with 
previous reports [25,26). 
In situ Hybridization Using MCP-1-specific 35S-labeled anti-
sense RNA-probes, specific signals were found in all viable layers of 
the epidermis and in the papillary dermis of psoriatic lesions. Over-
all labeling in the suprabasal layers was sparse but significantly 
higher than that of the sense control defining the background of the 
method. The density of signals appeared higher in the epidermis as 
compared to the dermal compartment. However, the most conspic-
uous and consistent finding was the detection of focally abundant 
silver grain precipitates over the basal epidermal layer of all psoriatic 
lesions tested (Figs 3A,3B). Interestingly, hybridization signals did 
not occur along the full length of the basal layer, but were preferen-
tially observed at the tips of the rete ridges. This pattern partly 
coincided with that seen by anti-S3 immunolabeling with prolifer-
ating S3+ keratinocytes, as described above (Fig 2). The specificity 
of these hybridization signals was confirmed using sense probes or 
predigestion with RNase, which did not produce cell-associated 
silver grains above the very low background. In addition, the use of 
full-length probes (> SOO bp) significantly increased the exposure 
time, which concomitantly increased the background signals. 
Sized-reduced riboprobes increased the signal-to-noise ratio and 
were therefore used in all ill situ hybridization procedures. 
It is noteworthy that within the foci of MCP-1 positivity the 
signal bands were continuous (Figs IB, 3A,B), suggesting that most 
of these basal epidermal cells are positive for MCP-l mRNA. At the 
margin between non-involved and involved skin, the number of 
MCP-l mRNA + basal cells was significantly decreased (Figs 4A,B). 
The adjacent non-involved skin of all biopsies studied as well as 
normal skin from healthy volunteers was devoid of any detectable 
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Figure 1. (A) Staining for dermal macrophages with monoclonal antibody 
anti-CD68 using a three-step streptABC-horseradish peroxidase method 
and AEC as substrate. CD68+ cells are arranged below the basement mem-
brane of the rete ridges and in the papillary space. (B) Serial section hybrid-
ized with MCP-l -spccific 35S anti-sense RNA probe. Si lver grain accumu-
lation indicating mRNA transcripts is localized to basal epidcrmal cells and 
the papillae (white arrows). Thus CD68+ sub-basal dermal macrophages as 
shown in A arc aligncd close the corrcsponding site of high MCP-l mRNA 
expression. Bar, 50 Jlm. 
MCP-l mRNA, with the rare exception of single weakly positive 
basal cells. 
In addition, cells with high expression of MCP-l transcripts were 
encountered in the upper portion of the papillary dermis of psoriatic 
lesions (Fig IB) . Single cells in the subpapillary upper dermal com-
partment also showed high levels of transcripts and these were 
mainly within clusters of infiltrating leukocytes (Figs 3A,B) . 
Comparing MCP-l mRNA expression and the preferential 10-
calization of CD68+ dermal macrophages (Figs lA,B), we fre-
quently (seven of nine lesions tested), but not consistently, observed 
that dermal macrophages lined the rete ridges in an infrabasal level. 
Thus, these dermal macrophages were found in the immediate vi-
cinity of basal cells with a high level of MCP-l mRNA expression 
(Fig IB). In addition, CD68+ dermal macrophages also accumu-
lated in the papillae and within clusters of leukocytes in the subpa-
pillary upper compartment, where cells with high MCP-l mRNA 
expression have been encountered (Fig IB) . In contrast to the afore-
mentioned correlation between MCP-l mRNA expression and the 
localization of dermal macrophages, such observations were not 
made when CD3+ and neutrophil elastase positive cells were labeled 
on sequential sections. This suggests that MCP-l exhibits selective 
chemotactic properties for macrophages but not for T lymphocytes 
and neutrophils it'l vivo. 
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Figure 2. Staining of psoriatic lesion with the monoclonal antibody S3, 
specific for proliferating cells. S3+ ce lls are restricted to the lower epidermal 
compartmcnt, prcferentially the first and second basal layer of the rete 
ridges. The dermal compartment is devoid of any proliferating cells. Three-
step streptavidin-biotin-horseradish peroxidase staining with AEC substrate 
and use of intcrfercncc-contrast microscopy. Bar, 50 Jim. 
DISCUSSION 
The levels of multiple factors/cytokines are known to be altered in 
psoriasis, as compared to normal skin or other dermatoses, but it is 
not known how these changes tie into the cascade of events that 
eventually lead to the morphogenesis of psoriatic lesions. 
In the present ill situ study, we have directed our attention both to 
dermal macrophages, which, together with neutrophils and T lym-
phocytes, may have a key role in psoriasis pathogenesis, and to 
MCP-l as a potent chemotactic cytokines that could guide these 
dermalmacrophages to sites where MCP-l is released. Our results 
show that MCP-l mRNA is highly expressed in lesional psoriatic 
skin but not in uninvolved psoriatic or normal skin. Of equal im-
portance is the particularly high expression of MCP-l in the basal 
layer of the rete ridges. Furthermore, we detected a correlation 
between MCP-lmRNA expression in basal cells and the accumula-
tion of CD68+ dermal macrophages in the direct vicinity of the 
subepidermal region, suggesting selective chemotactic properties of 
MCP-l on macrophages ill villo. The band-like hybridization pat-
tern, with every basa l cell in a row expressing MCP-l mRNA, 
strongly suggests that basal keratinocytes rather than melanocytes 
are the m<tior source ofMCP-1. This conclusion is substantiated by 
the finding that freshly cultured melanocytes are devoid ofMCP-l 
message although they express high levels of NAP-l/IL-8 under 
the same condition (R. Gillitzer, H . K6ck, unpublished observa-
tions). Due to the elongation of the papillae and the rete ridges, in 
particular, the surface of the basal epidermal layer is drastically 
increased in psoriatic lesions. In parallel, the number of MCP-l 
mRNA-expressing keratinocytes is significantly elevated as com-
pared to normal skin. 
Thus far, significant post-transcriptional regulation of MCP-l in 
cultivated cells has not been reported. Assuming unrestricted trans-
lation of MCP-l transcripts into functional proteins also it'l lIivo, 
which is supported by detected immunoreactivity with MCP-l-
specific MoAb in the epidermal compartment as well as on some 
dermal cells (Gillitzer et ai, in preparation), this suggests that high 
levels of MCP-l are constantly released in and into the dermal 
compartment. Therefore, perhaps the most important implication 
of this study is a chemotactic gradient between the epidermal and 
dermal compartments in psoriatic lesions. Because the highest levels 
of MCP-l transcripts were found in the basal layer of the rete ridges, 
the steepest MCP-l gradient supposedly exists between the basal 
membrane and the sub-basal space where MCP-l clearance could 
occur through receptor-bearing target cells, cytokine-binding pro-
teins, and the lymphatic and blood drainage. This would partly 
explain the fact that dermal macrophages concentrate and line up 
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Figure 3. I" situ hybridization with 35S-labeled RNA anti-sense probes for MCP-l in a psoriatic lesion. MCP-l transcripts are highly abundant in basal 
epidermal cells of the rete ridges and encountered in cells of the papillary body. (A) Bright field illumination; (B) enhancement of silver precipitates with dark 
field illumination. Bar, 100 J.lm. 
Figure 4. I" situ hybridization for MCP-l mRNA expression at the continuous margin between non-involved and involved psoriatic skin using 35S-labeled 
RNA anti-sense probe. MCP-t mRNA expression is mainly restricted to basal epidermal cells and is less abundant as compared to psoriatic lesions (Fig 3A, B) . 
(A) bright field; (B) dark field illumination. Bar, 50 J.lm. 
along the dermal/epithelial junction without entering the epider-
mis. Just recently, detailed ultrastructural analysis revealed that oc-
casionally the basal membrane is interrupted at sites where basal 
keratinocytes and lining macrophages are in close proximity," sup-
porting our hypothesis that there exist intensive interactions be-
tween both cell types. Moreover, MCP-1- producing cells in the 
dermis, albeit in smaller numbers compared to basal keratinocytes, 
may influence the location of macrophages. 
The MCP-1 transcripts in the few scattered cells at the tips of the 
papillae could be responsible for the accumulation of dermal macro-
phages in this region. Whether an additional barrier (e.g., chemo-
tactic stimuli and adhesion molecules within the dermal compart-
ment) to macrophage exocytosis exists is still unknown. In contrast 
to dermal macrophages, neutrophils face the highest concentration 
of chemotactic molecules in the upper stratum malphigii, which in 
psoriasis contains focal clusters of keratinocytes expressing high 
levels of NAP-1/IL-8 mRNA message [2], eicosanoids, and CSa 
[24] . As a result, neutrophils migrate through the epidermis and 
characteristically cluster in the upper malpighian layer and/or the 
parakeratotic stratum corneum. 
The role of dermal macrophages in the subbasal spaces is not 
known and equally unknown is their capacity to secrete cytokines 
• Wortmann S, Boehnke W-H, Mielke V, Sterry W, Kaufmann R: Ul-
trastructure of macrophages lining the epidermo-dermal border in psoriatic 
skin ("lining cells") (abstr). Arch Dermatol 285:85, 1993. 
that could, in turn, stimulate keratinocytes. Whereas we were not 
able to detect TNF-a message in dermal cells by in situ hybridiza-
tion [2], others have shown by immunohistologic methods that 
dermal macrophages express TNF-a reactivity [34]. This, however, 
does not prove a de novo synthesis of TNF-a but could also reflect 
binding to TNF-a-specific surface receptors, which are known to 
be abundant on monocytes. On the other hand, the proximity of 
dermal macrophages to the highly proliferative basal keratinocytes 
is strongly suggestive of a dialogue between both cell types. MCP-l 
may be considered to be one of the signals of communication and 
further functional studies are needed to elucidate whether MCP-l is 
not only chemotactic but also functions as an activating signal, as 
suggested by Matsushima et at [8]. As the ill situ technique used in the 
present study docs not allow the simultaneous localization of cyto-
kine mRNA and leukocyte subtype-specific antigens, the few scat-
tered cells responsible for the MCP-1 mRNA transcripts in the 
dermis remain unknown. Fibroblasts [11 ,12], endothelial cells 
[12,13]' lymphocytes [10], and even monocytes themselves [6] 
could account for dermal MCP-l message. 
In tumor cell lines, MCP-l secretion in vitro does not require the 
presence of known stimuli (summarized in [36]), but for other cells, 
multiple cytokines are known to induce and modulate MCP-l ex-
pression. Among them are TNF-a [12,17,37], IL-1 [7,10,11], and 
IFN-y [14,18], which may exhibit synergistic effects [14]. Conflict-
ing results exist concerning the level ofIL-1 (IL-l a and IL-l If) and 
TNF-a in psoriatic skin. Some investigators found elevated levels 
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for IL-1 [28,29], whereas others reported decreased IL-1 concentra-
tions in ,£soriatic lesions [16,30,31]. With respect to TNF-O', nei-
ther we l2] nor others [16] have been able to detect elevated concen-
trations on the ill situ mRNA level and the protein level, 
respectively. 
PDGF-B could also be considered a triggering signal for MCP-1 
expression because it has been shown to be produced by keratino-
cytes [38] and other cells that constitute psoriatic lesions (fibroblasts, 
endothelial cells). Indeed, we have found elevated levels ofPDGF-
B expression in dermal cells of psoriatic lesions (Gillitzer et ai, in 
preparation). Because keratinocytes ill vivo do not express detectable 
levels of the appropriate receptor subtype for PDGF-B (PDGF-p-
type receptor) [34] it may be assumed that dermal rather than epi-
dermal cells are the appropriate targets. Interestingly, PDGF has 
been reported to exhibit direct chemotactic properties for macro-
phages [39] and, therefore, could directly stimulate monocyte che-
motaxis. 
Although the role of MCP-l in the initiation of psoriatic lesions 
remains to be elucidated, its high expression in continuous, though 
focally localized, populations of basal epidermal cells suggests an 
important role of this molecle in the pathogenesis of psoriatic le-
sions. Our microanatomic analysis of MCP-1 mRNA expression 
may help to explain one of the pathologic features typical for psori- . 
asis, such as the almost exclusive accumulation of dermal macro-
phages in the subepidermal space. 
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